Who are MEXILETINE HYDROCHLORIDE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Cordarone, Norpace Cr, Bupivacaine Hydrochloride And Epinephrine, Bupivacaine Hydrochloride, Bupivacaine Hydrochloride And Epinephrine, Bupivacaine Hydrochloride And Epinephrine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mexiletine-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

MEXILETINE HYDROCHLORIDE — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed sodium channels Small molecule Live · refreshed every 30 min

Target snapshot

MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE). Mexiletine, an oral antiarrhythmic, reduces ventricular arrhythmias by inhibiting sodium currents and altering refractory periods.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
MEXILETINE HYDROCHLORIDE TARGET	MEXILETINE HYDROCHLORIDE		marketed		sodium channels	1985-01-01
Cordarone	AMIODARONE	Pfizer	marketed	Antiarrhythmic	sodium channels, potassium channels, calcium channels	1985-01-01
Norpace Cr	Disopyramide Phosphate	Pfizer	marketed	Type 1 antiarrhythmic	Cardiac sodium channels; cardiac cells with augmented automaticity	1977-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01
Bupivacaine Hydrochloride	Bupivacaine Hydrochloride	Pfizer	marketed	Amide-type local anesthetic	Nerve sodium channels	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01
Bupivacaine Hydrochloride And Epinephrine	Bupivacaine Hydrochloride	Pfizer	marketed	Amide local anesthetic	Nerve sodium channels	1972-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-05-20 — Bupivacaine Hydrochloride · RE47826 · US
2034-03-13 — Bupivacaine Hydrochloride · 10398686 · US
2034-03-13 — Bupivacaine Hydrochloride · 11253504 · US
2034-03-13 — Bupivacaine Hydrochloride · 9592227 · US
2034-03-13 — Bupivacaine Hydrochloride · 9744163 · US
2034-03-13 — Bupivacaine Hydrochloride · 9913909 · US
2035-04-20 — Bupivacaine Hydrochloride · 9694079 · US
2035-04-20 — Bupivacaine Hydrochloride · 9801945 · US
2035-04-20 — Bupivacaine Hydrochloride · 10098957 · US
2035-04-20 — Bupivacaine Hydrochloride · 10213510 · US
2035-04-20 — Bupivacaine Hydrochloride · 10632199 · US
2035-04-20 — Bupivacaine Hydrochloride · 10898575 · US
2035-04-20 — Bupivacaine Hydrochloride · 10980886 · US
2035-04-20 — Bupivacaine Hydrochloride · 11083730 · US
2035-04-20 — Bupivacaine Hydrochloride · 11083797 · US
2035-04-20 — Bupivacaine Hydrochloride · 11413350 · US
2041-01-12 — Bupivacaine Hydrochloride · 11400019 · US
2041-01-22 — Bupivacaine Hydrochloride · 11452691 · US
2041-01-22 — Bupivacaine Hydrochloride · 11179336 · US
2041-01-22 — Bupivacaine Hydrochloride · 11278494 · US
2041-01-22 — Bupivacaine Hydrochloride · 11304904 · US
2041-01-22 — Bupivacaine Hydrochloride · 11311486 · US
2041-01-22 — Bupivacaine Hydrochloride · 11357727 · US
2041-01-22 — Bupivacaine Hydrochloride · 11426348 · US
2041-01-22 — Bupivacaine Hydrochloride · 11033495 · US

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MEXILETINE HYDROCHLORIDE — Competitive Intelligence Brief. https://druglandscape.com/ci/mexiletine-hydrochloride. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab